Design and evaluation of cyclodextrin-based drug formulation

被引:277
作者
Uekama, K [1 ]
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan
关键词
cyclodextrin derivative; inclusion complex; cyclodextrin/drug conjugate; absorption enhancement; controlled drug release; site-specific drug delivery;
D O I
10.1248/cpb.52.900
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The pharmaceutically useful cyclodextrins (CyDs) are classified into hydrophilic, hydrophobic, and ionic derivatives. Because of the multi-functional characteristics and bioadaptability, these CyDs are capable of alleviating the undesirable properties of drug molecules through the formation of inclusion complexes or the form of CyD/drug conjugates. This review outlines the current application of CyDs in design and evaluation of CyD-based drug formulation, focusing on their ability to enhance the drug absorption across biological barriers, the ability to control the rate and time profiles of drug release, and the ability to deliver a drug to a targeted site.
引用
收藏
页码:900 / 915
页数:16
相关论文
共 174 条
[71]   ISOLATION AND CHARACTERIZATION OF BRANCHED CYCLODEXTRINS [J].
KOIZUMI, K ;
UTAMURA, T ;
SATO, M ;
YAGI, Y .
CARBOHYDRATE RESEARCH, 1986, 153 (01) :55-67
[72]  
Kondo A, 1996, BIOL PHARM BULL, V19, P280
[73]   IMPROVEMENT OF SOME PHARMACEUTICAL PROPERTIES OF NOCLOPROST BY BETA-CYCLODEXTRIN AND GAMMA-CYCLODEXTRIN COMPLEXATION [J].
KURIHARA, M ;
HIRAYAMA, F ;
UEKAMA, K ;
YAMASAKI, M .
JOURNAL OF INCLUSION PHENOMENA AND MOLECULAR RECOGNITION IN CHEMISTRY, 1990, 8 (04) :363-373
[74]   Pharmaceutical applications of cyclodextrins .1. Drug solubilization and stabilization [J].
Loftsson, T ;
Brewster, ME .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (10) :1017-1025
[75]   CONTROLLED-RELEASE OF THE LHRH AGONIST BUSERELIN ACETATE FROM INJECTABLE SUSPENSIONS CONTAINING TRIACETYLATED CYCLODEXTRINS IN AN OIL VEHICLE [J].
MATSUBARA, K ;
IRIE, T ;
UEKAMA, K .
JOURNAL OF CONTROLLED RELEASE, 1994, 31 (02) :173-180
[76]   IMPROVEMENT OF NASAL BIOAVAILABILITY OF LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST, BUSERELIN, BY CYCLODEXTRIN DERIVATIVES IN RATS [J].
MATSUBARA, K ;
ABE, K ;
IRIE, T ;
UEKAMA, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (11) :1295-1300
[77]  
Matsubara K, 1997, CHEM PHARM BULL, V45, P378
[78]   Protection afforded by maltosyl-beta-cyclodextrin against alpha-chymotrypsin-catalyzed hydrolysis of a luteinizing hormone-releasing hormone agonist, buserelin acetate [J].
Matsubara, K ;
Ando, Y ;
Irie, T ;
Uekama, K .
PHARMACEUTICAL RESEARCH, 1997, 14 (10) :1401-1405
[79]  
MATSUBARA K, 1990, DRUG DELIVERY SYSTEM, V5, P95
[80]   Cyclodextrins in transdermal and rectal delivery [J].
Matsuda, H ;
Arima, H .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 36 (01) :81-99